METHOD OF INHIBITING NEUROTROPHIN-RECEPTOR BINDING
申请人:QUEEN'S UNIVERSITY AT KINGSTON
公开号:EP1185515A1
公开(公告)日:2002-03-13
US6492380B1
申请人:——
公开号:US6492380B1
公开(公告)日:2002-12-10
[EN] METHOD OF INHIBITING NEUROTROPHIN-RECEPTOR BINDING<br/>[FR] PROCEDE D'INHIBITION DE LA LIAISON AU RECEPTEUR DE NEUROTROPHINE
申请人:UNIV KINGSTON
公开号:WO2000069828A1
公开(公告)日:2000-11-23
The present invention relates to compositions which inhibit the binding of nerve growth factor to the p75NTR common neurotrophin receptor and methods of use thereof. In one embodiment, the compound which inhibits binding of nerve growth factor to p75NTR comprises, particularly when bound to nerve growth factor, at least two of the following: (1) a first electronegative atom or functional group positioned to interact with Lys34 of nerve growth factor; (2) a second electronegative atom or functional group positioned to interact with Lys95 of nerve growth factor; (3) a third electronegative atom or functional group positioned to interact with Lys88 of nerve growth factor; (4) a fourth electronegative atom or functional group positioned to interact with Lys32 of nerve growth factor; and (5) a hydrophobic moiety which interacts with the hydrophobic region formed by Ile?31, Phe101¿ and Phe86 of nerve growth factor.
Method of inhibiting neurotrophin-receptor binding
申请人:Queen's University at Kingston
公开号:US06492380B1
公开(公告)日:2002-12-10
The present invention relates to compositions which inhibit the binding of nerve growth factor to the p75NTR common neurotrophin receptor and methods of use thereof. In one embodiment, the compound which inhibits binding of nerve growth factor to p75NTR comprises, particularly when bound to nerve growth factor, at least two of the following: (1) a first electronegative atom or functional group positioned to interact with Lys34 of nerve growth factor; (2) a second electronegative atom or functional group positioned to interact with Lys95 of nerve growth factor; (3) a third electronegative atom or functional group positioned to interact with Lys88 of nerve growth factor; (4) a fourth electronegative atom or functional group positioned to interact with Lys32 of nerve growth factor; and (5) a hydrophobic moiety which interacts with the hydrophobic region formed by Ile31, Phe101 and Phe86 of nerve growth factor.